Hedy Kindler
Section of Hematology / Oncology
Professor of Medicine
Director, Gastrointestinal Oncology; Director, Mesothelioma Program
Referring Physician Access Line: 1-877-DOM-2730

Training

DegreeYearInstitutionArea
BS1982Yale UniversityBiology
MD1989State University of New York 
Residency1991University of California Los AngelesInternal Medicine
Residency1992Montefiore Medical CenterInternal Medicine
Fellowship1995Memorial Sloan-Kettering Cancer CenterHematology/Oncology

Academic Interests

Dr. Kindler's research focuses on new drug development for the treatment of malignant mesothelioma, advanced pancreatic cancer and other gastrointestinal malignancies. She designs and conducts clinical trials of novel agents, including angiogenesis inhibitors and other targeted drugs, for patients with these cancers. She is the chair of the Mesothelioma Subcommittee of the Cancer and Leukemia Group B, a multicenter research organization funded by the National Cancer Institute to conduct clinical trials in malignant mesothelioma and other cancers.


Clinical Interests

Pancreatic Cancer, malignant mesothelioma, colorectal cancer, gastrointestinal stromal tumors (GIST), hepatobiliary cancers.


Representative Publications

  1. Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR. Weekly, high-dose paclitaxel in advanced lung carcinoma: A phase II study with pharmacokinetics by the Cancer and Leukemia Group B. Cancer 97:2480-2486, 2003.
  2. Kindler HL, Avadhani A, Mani S, Vokes EE. A phase II trial of 9-Aminocamptothecin administered as a 120-hour continuous infusion in patients with advanced gastric cancer. Investigational New Drugs 22:323-7, 2004.
  3. Otterson GA, Herndon JE II, Watson D, Terrenoire J, Green MR, Kindler HL. Capecitabine in Malignant Mesothelioma: A Phase II Trial by the Cancer and Leukemia Group B. Lung Cancer, 44:251-259, 2004.
  4. Armato SG III, Oxnard GR, MacMahon H, Vogelzang NJ, Kindler HL, Kocherginsky M, Starkey A. Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computer-assisted techniques. Medical Physics 31(5): 1105-1115, 2004.
  5. Eng C, Kindler HL, Nattam S, Ansari RH, Kasza K, Wade-Oliver K, Vokes EE. Phase II trial of the epothilone analogue BMS-247550 in patients with advanced colorectal cancer. Annals of Oncology, 15: 928-932, 2004.



More Information

For more information about Dr. Hedy Kindler publications and research collaborations , please click here